They'll need the data from one of the COVID cohorts first. All indications point to positive results plus it didn't hurt that the clinical trial specialist credits Leronlimab for "curing" him of COVID recently and he helped fill the two clin trial cohorts. Dr.P in his last webcast hinted it's possible there could be a conditional approval this year.
News 
Market Data 
Discover 
